ORIC - Balance Sheet - ORIC Pharmaceuticals, Inc.

Current Liabilities	24.8 M
Accounts Payable	1.55 M
Short-Term Debt	0
Other Current Liabilities	23.3 M
Non-Current Liabilities	6.17 M
Long-Term Debt	0
Other Non-Current Liabilities	6.17 M

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019	Dec-2018	Dec-2017
ASSETS
Cash & Cash Equivalents	59.4	23.4	66.8	226.0	78.4	89.2	42.6	25.8
Short Term Investments	196.6	184.8	139.4	11.0	215.2	0	0	0
Receivables	0	0	0	0	0	0	0	0
Inventory	0	0	0	0	0	0	0	0
Other Current Assets	6.3	4.4	4.2	7.1	6.2	0.8	1.1	0.8
Total Current Assets	262.2	212.6	210.5	240.5	296.7	90.0	43.7	26.6
PP&E	2.9	12.0	3.3	2.4	2.0	2.2	2.5	2.9
Intangible Assets	0	0	0	0	0	0	0	0
Goodwill	0	0	0	0	0	0	0	0
Long Term Investments	0	26.9	22.0	43.4	0	0	0	0
Other Long Term Assets	9.0	0.6	11.5	12.3	0.3	1.9	0.5	0.5
Other Assets	0	0	0	0	0	0	0	1
Total Assets	274.1	252.0	247.2	298.6	299.0	94.1	46.7	30.0
LIABILITIES
Accounts Payable	1.5	0.9	1.3	1.9	0.8	0.2	0.4	0.9
Short Term Debt	0	2.8	2.7	1.9	0	0	0	0
Other Current Liabilities	23.3	16.8	11.4	11.3	8.2	4.7	1.7	1.3
Total Current Liabilities	24.8	20.5	15.4	15.2	9.0	5.4	2.6	2.6
Long Term Debt	0	0	0	0	0	0	0	0
Deferred Tax Income	0	0	3.2	3.4	0	0	0	0
Other Liabilities	6.2	7.5	9.4	10.5	0.2	0	107.3	0
Total Liabilities	31.0	27.9	24.8	25.7	9.2	6.1	111.2	4.3
EQUITY
Common Stock	7 K	6 K	5 K	4 K	4 K	2 K	1 K	1 K
Retained Earnings	(562.8)	(434.9)	(334.2)	(245.1)	(166.4)	(92.7)	(65.8)	(44.4)
Other Accumulative Comprehensive Income/Loss	0.4	0.3	(1.3)	(0.1)	31 K	(178.1)	(2.6)	0
Total Equity	243.1	224.1	222.4	273.0	289.8	88.0	(64.4)	25.7
Total Liabilities and Equity	274.1	252.0	247.2	298.6	299.0	94.1	46.7	30.0
SHARES OUTSTANDING
Common Shares Outstanding	69.7	51.5	39.7	38.0	21.9	29.9	19.1	29.9

Free